GAMMA Investing’s Kazia Therapeutics KZIA Stock Holding History

GAMMA Investing’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.1K	Buy	1,926 +358	+23%	+$4.36K	﹤0.01%	2678
2026 Q1	$11.7K	Buy	1,568 +1,336	+576%	+$9.3K	﹤0.01%	2991
2025 Q4	$1.6K	Buy	+232	New	+$1.98K	﹤0.01%	3669
2025 Q3	–	Sell	-265	Closed	-$1.66K	–	3894
2025 Q2	$1.66K	Hold	265	–	–	﹤0.01%	3439
2025 Q1	$1.04K	Buy	+265	New	+$1.57K	﹤0.01%	3552

Other funds holding KZIA

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

UBV

United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

GAMMA Investing's KZIA Position: Q2 2026 in Review

GAMMA Investing increased its Kazia Therapeutics (KZIA) stake by 23% in Q2 2026, buying an estimated $4.36K and bringing the position to 1,926 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

GAMMA Investing first reported a position in KZIA in Q1 2025 and has held it in 5 quarters since. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

GAMMA Investing held 1,926 shares of Kazia Therapeutics worth $27.1K as of Q2 2026.
GAMMA Investing bought 358 Kazia Therapeutics shares in Q2 2026, an estimated $4.36K.
Kazia Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2678 holding.
GAMMA Investing first reported a position in Kazia Therapeutics in Q1 2025 and has held it in 5 quarters since.
6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.